Yu Joanne L, Rak Janusz W
Henderson Research Centre, McMaster University, Hamilton, Ontario, Canada.
Breast Cancer Res. 2003;5(2):83-8. doi: 10.1186/bcr573. Epub 2003 Feb 3.
Breast cancer progression is associated with and dependent upon robust neovascularization. It is becoming clear that tumour-associated 'normal' cells, such as immune/inflammatory cells, endothelial cells and stromal cells, conspire with cancer cells in promoting this process. In particular, infiltrating immune/inflammatory cells secrete a diverse repertoire of growth factors and proteases that enable them to enhance tumour growth by stimulating angiogenesis and, as we suggest here, by promoting 'tumour arteriogenesis' - enlargement of feeding vessels supplying the expanding tumour capillary bed. Macrophages and their chemoattractants (e.g. macrophage chemoattractant protein-1) are critical for the arteriogenic process in ischaemia, and probably also in breast neoplasia. A better understanding of these various cellular and molecular constituents of breast cancer neovascularization may be useful in designing more effective therapies.
乳腺癌进展与强大的新血管形成相关且依赖于此。越来越清楚的是,肿瘤相关的“正常”细胞,如免疫/炎症细胞、内皮细胞和基质细胞,与癌细胞共同促进这一过程。特别是,浸润的免疫/炎症细胞分泌多种生长因子和蛋白酶,使其能够通过刺激血管生成,以及如我们在此所提出的,通过促进“肿瘤动脉生成”——为不断扩大的肿瘤毛细血管床供血的血管增大,来增强肿瘤生长。巨噬细胞及其趋化因子(如巨噬细胞趋化蛋白-1)对缺血中的动脉生成过程至关重要,在乳腺肿瘤形成中可能也是如此。更好地理解乳腺癌新血管形成的这些不同细胞和分子成分,可能有助于设计更有效的治疗方法。